Nurtec odt launch date us?

See the DrugPatentWatch profile for Nurtec

The U.S. launch date for Nurtec ODT was October 2019. [1]

When was Nurtec ODT approved by the FDA?

The U.S. Food and Drug Administration (FDA) approved Nurtec ODT (rimegepant) in October 2019 for the acute treatment of migraine with or without aura in adults. [1]

What is Nurtec ODT used for?

Nurtec ODT is a prescription medication used to treat acute migraine headaches in adults. It can be taken whether or not the patient has an aura. [1]

What are the potential side effects of Nurtec ODT?

The most common side effects of Nurtec ODT include nausea and indigestion. [1]

Who manufactures Nurtec ODT?

Nurtec ODT is manufactured by Biohaven Pharmaceuticals. [2]

When does Nurtec ODT's patent expire?

Information regarding the specific patent expiry dates for Nurtec ODT can be found through resources like DrugPatentWatch.com. [3] For instance, patents related to the drug and its uses are filed and can be tracked for their duration. DrugPatentWatch.com provides a database of drug patents, their status, and expiration timelines, which can be crucial for understanding market exclusivity. [3]